Key result
TTE detects cardiac involvement in 1.5% of malignant lymphoma patients, primarily diffuse large B-cell lymphoma.
Why the study?
Diagnosing cardiac involvement in malignant lymphoma without cardiac manifestations is difficult.
Observational (n=453)
No
Routine transthoracic echocardiography in patients with malignant lymphoma reveals a 1.5% incidence of cardiac involvement, most commonly associated with diffuse large B-cell lymphoma and frequently presenting as pericardial effusion.
Answers are grounded in this paper and cite their sources.
Low detection rate suggests limited utility of routine TTE; hypothesis-generating for targeted screening strategies in lymphoma.
Objective Although malignant lymphoma (ML) can occur in every organ, diagnosing cardiac involvement without cardiac manifestations is difficult. We therefore investigated the incidence of cardiac involvement in ML in our hospital and clarified the transthoracic echocardiography (TTE) findings of cardiac involvement. Methods Patients with ML referred to our hospital between January 2013 and December 2019 were retrospectively reviewed. Patients During the study period, 453 patients were identified. The mean age was 64.9 years old, and 54% of the patients were men. Results Diffuse large B-cell lymphoma (DLBCL) was the most common lymphoma, followed by follicular lymphoma. Of the 453 patients, 394 (87.0%) underwent TTE at the initial diagnosis or during the clinical course. The performance rates of TTE in DLBCL, Hodgkin lymphoma, and mantle cell lymphoma were above 90%. Cardiac involvement was detected in 6 (five with DLBCL and one with B-cell lymphoma) (1.5%) of the 394 patients who underwent TTE. The involved lesions of the heart varied, and five patients had pericardial effusion. Five patients had a preserved left ventricular ejection fraction. All patients were treated with chemotherapy, and some were treated with radiation and surgery. Conclusion Cardiac involvement was observed in six (1.5%) of the patients with ML who underwent TTE. B-cell lymphoma, especially DLBCL, is a common ML with cardiac involvement. Although five patients had pericardial effusion, the involved lesions of the heart were not uniform. TTE is a useful imaging modality to noninvasively and repeatedly evaluate the tumor characteristics, response to ML treatment, and cardiac function.
No takes yet. Share an insight, caveat, or question.
Ebina et al. (2023) conducted an observational in Malignant lymphoma (n=453). Transthoracic echocardiography (TTE) was evaluated on Incidence of cardiac involvement detected by TTE. Cardiac involvement was detected by transthoracic echocardiography in 1.5% (6 of 394) of patients with malignant lymphoma, with diffuse large B-cell lymphoma being the most common type involved.
Synapse has enriched 10 related papers. Consider them for comparative context: